San Antonio Researcher, Educator Brings Expertise to Organization's Focus
on Breast Cancer Disparities
DALLAS, Oct. 2 /PRNewswire/ -- Susan G. Komen for the Cure, the global leader in the breast cancer movement, has appointed Amelie G. Ramirez, DrPH, of San Antonio, to its Scientific Advisory Board.
Ramirez joins a group of five other leading breast cancer researchers and clinicians who comprise Komen's Scientific Advisory Board. The group's leader is Dr. Eric P. Winer, internationally known medical oncologist, researcher and educator from the Dana-Farber Cancer Institute and Harvard Medical Center, who is Komen's chief scientific advisor. Komen's Scientific Advisory Board lends insight and guidance to Komen in its grantmaking and health education initiatives. Komen's Scientific Advisory Board members also provide expert perspective and commentary on breaking news and emerging developments in breast cancer research and treatment.
Ramirez, who also serves as chairman of Komen's National Hispanic/Latino Advisory Council, is a professor of epidemiology and biostatistics at the University of Texas Health Science Center at San Antonio (UTHSCSA), where she also is founding director of the Institute for Health Promotion Research. In 2006, Dr. Ramirez received two endowments to support her research and that of the Institute. At UTHSCSA, she was named the Dielmann Chair in Health Disparities Research and Community Outreach. At the Cancer Therapy and Research Center (CTRC) in San Antonio, Dr. Ramirez was given the Max and Minnie Tomerlin Voelcker Endowed Chair in Cancer Healthcare Disparities and Outreach. Dr. Ramirez is director of outreach and health disparities at the CTRC.
Over the past 25 years, she has directed numerous state-, federal- and privately funded research programs focusing on human and organizational communication to reduce chronic disease and cancer health disparities affecting Hispanics/Latinos and other populations. She has authored numerous peer-reviewed articles and is frequently invited to speak at scientific meetings.
Ramirez is a former member of the National Cancer Advisory Board and the National Heart, Lung, and Blood Advisory Council of the National Institutes of Health.
"Dr. Ramirez's unique expertise and keen insight has proven invaluable to Komen identifying and addressing breast health disparities among specific population groups, including Hispanic and Latino people. As a member of its Scientific Advisory Board (SAB), Dr. Ramirez will be instrumental in Komen's ability to reach even more deeply into areas of our society that remain medically underserved," said Dr. Winer.
In addition to Dr. Winer and Dr. Ramirez, the SAB includes the following physicians and researchers:
-- Melissa L. Bondy, Ph.D., professor of epidemiology at the University of
Texas M.D. Anderson Cancer Center, Houston, and director of the
Childhood Cancer Epidemiology and Prevention Center, a collaborative
program between M.D. Anderson Cancer Center, Baylor College of Medicine
and Texas Children's Hospital.
-- Powel Brown, professor of medicine, Baylor College of Medicine;
associate director of cancer prevention and director of cancer
prevention and populations studies program, Dan L. Duncan Cancer
Center; and associate director of research at the Breast Care Center
-- H. Kim Lyerly, M.D., George Barth Geller Professor of Research at Duke
University, Durham, N.C.; director of the Duke Comprehensive Cancer
Center and principal investigator of the Duke Specialized Program in
Research Excellence (SPORE).
-- George W. Sledge, M.D., Ballve-Lantero Professor of Oncology and
co-director of the breast cancer program at the Indiana University
Cancer Center. He is also professor of medicine and pathology at
Indiana University School of Medicine. Dr. Sledge was awarded the Komen
Brinker Award of Scientific Distinction in 2006.
-- Sara Sukumar, Ph.D., professor of oncology and pathology and co-
director of the breast cancer research program at the Sidney Kimmel
Cancer Center at Johns Hopkins University School of Medicine in
About Susan G. Komen for the Cure
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org or call 1-800 I'M AWARE.
|SOURCE Susan G. Komen for the Cure|
Copyright©2007 PR Newswire.
All rights reserved